In a world where health systems are increasingly focused on value-based pricing and personalized treatments, the heightened emphasis on scientific exchange between the pharmaceutical, biotech, medical device and diagnostic industry and its customers has never been greater. The perception that […]
Read MoreOn first hearing what’s been going on in the disputes between brand drug companies and their generic competitors over obtaining samples for testing, the initial reaction is, here’s an obscure digression from the grand process of drugs going off-patent, who […]
Read More
One of the attributes of the burgeoning specialty pharmaceutical market in the US is that many of the products are moving through distribution channels via nontraditional channels. Part of this is due to their very nature—they often require special handling […]
Read More
By all counts, the global pharma traceability initiative—driven by the Drug Supply Chain Security Act (DSCSA) in the US, and the Falsified Medicines Directive in Europe—is moving ahead, with equipment and software contracts being placed, and project managers getting to […]
Read MoreThe category of enterprise quality management software (EQMS) has been around for quite a while, and managers in clinical trials, plant manufacturing and laboratories have been accustomed to employing these systems to collect data, organize it, and manage documents. A […]
Read MoreLisa A. Butler, newly elected president of the PDMA Alliance, has been an Alliance Board Member for the past three years. She is an associate director of DEA/PDMA Compliance for Novartis Business Services. For the last 25 years, she has […]
Read More
Having the privilege to serve on the Alliance’s board affords me an enormous and gratifying experience, highlighted by the opportunity to participate in developing a new conference program each year. From the end of one year’s conference to the next, […]
Read More
When looked at as a unified market, cardiovascular disease (CVD) is a very large, heavily populated ecosystem, inhabited by large numbers of healthcare delivery systems, therapeutic drugs, medical devices and drug/device combinations, patient support systems and advocacy groups. All this […]
Read MorePangea IX, this year’s effort to police the distribution of fake or illicit drugs, and the websites that promote them to unwitting consumers, concluded on June 7. According to press statements from FDA and Interpol, the international police organization, the […]
Read More
As one of the Big Four accounting and advisory firms, Deloitte deals with a large portion of the pharmaceutical industry, both domestically and internationally. In fact, the company says that it has not only the leading position with pharma, […]
Read More
